FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3209289701> ?p ?o ?g. }

• W3209289701 endingPage "153843" @default.
• W3209289701 startingPage "153843" @default.
• W3209289701 abstract "Obesity is the cause of multiple metabolic disorders, and its incidence has been rapidly increasing worldwide. It develops when energy intake exceeds energy expenditure (EE). Wedelolactone (WDL) is a naturally isolated compound from Eclipta prostrata L. and possesses many pharmacological activities. However, little is known about the effect of WDL on obesity and EE.The present study aimed to investigate the effect of WDL on obesity and EE in diet-induced obese (DIO) mice and its underlying mechanism.Obese mice were induced by high fat diet. The effects of WDL on obese mice were assessed by examining body weight, fat mass, EE, glucose tolerance, and hepatic and kidney injury. 3T3-L1 cells were differentiated into mature adipocytes and incubated with WDL in vitro. Immunohistochemistry, western blotting, and real-time PCR were used to assess adipose browning. The inhibitory efficiency of WDL on nicotinamide N-methyltransferase (NNMT) was evaluated using a fluorescence assay.WDL reduced fat mass, suppressed body weight gain, and improved obesity-related metabolic disorders in DIO mice. WDL treatment promoted adipose browning and enhanced EE in both DIO mice and 3T3-L1 cells. These effects were eliminated in AMPK antagonized or PPARα knockdown cells and in PPARα-/- mice. Furthermore, we identified the target of WDL to be NNMT, an appealing target for regulating energy metabolism. WDL inhibited NNMT with an extremely low IC50 of 0.03 µM. Inhibition of NNMT and activation of SIRT1/AMPK/PPARα explains how WDL reverses obesity by prompting adipose browning.Our findings demonstrate the novel effects of WDL in promoting adipose browning, enhancing EE and attenuating obesity and uncover the underlying mechanism, which includes inhibition of NNMT and subsequently activation of SIRT1/AMPK/PPARα in response to WDL. WDL could be further developed as a therapeutic agent for treating obesity and related metabolic diseases." @default.
• W3209289701 created "2021-11-08" @default.
• W3209289701 creator A5000776473 @default.
• W3209289701 creator A5007506985 @default.
• W3209289701 creator A5009827155 @default.
• W3209289701 creator A5021604240 @default.
• W3209289701 creator A5026424113 @default.
• W3209289701 creator A5043614299 @default.
• W3209289701 creator A5048082989 @default.
• W3209289701 creator A5048301510 @default.
• W3209289701 creator A5048718447 @default.
• W3209289701 creator A5052212622 @default.
• W3209289701 creator A5068313104 @default.
• W3209289701 creator A5077541525 @default.
• W3209289701 creator A5080815038 @default.
• W3209289701 creator A5083114703 @default.
• W3209289701 creator A5085214820 @default.
• W3209289701 creator A5085368591 @default.
• W3209289701 creator A5090914980 @default.
• W3209289701 creator A5091138158 @default.
• W3209289701 date "2022-01-01" @default.
• W3209289701 modified "2023-10-18" @default.
• W3209289701 title "Phytochemical wedelolactone reverses obesity by prompting adipose browning through SIRT1/AMPK/ PPARα pathway via targeting nicotinamide N-methyltransferase" @default.
• W3209289701 cites W1572576224 @default.
• W3209289701 cites W1981525131 @default.
• W3209289701 cites W1985819704 @default.
• W3209289701 cites W1993554808 @default.
• W3209289701 cites W2013823431 @default.
• W3209289701 cites W2027753197 @default.
• W3209289701 cites W2031050244 @default.
• W3209289701 cites W2062481845 @default.
• W3209289701 cites W2075199222 @default.
• W3209289701 cites W2119649463 @default.
• W3209289701 cites W2532265207 @default.
• W3209289701 cites W2618084078 @default.
• W3209289701 cites W2766101584 @default.
• W3209289701 cites W2782747552 @default.
• W3209289701 cites W2941157636 @default.
• W3209289701 cites W2942537534 @default.
• W3209289701 cites W2946680409 @default.
• W3209289701 cites W2981887664 @default.
• W3209289701 cites W3025824348 @default.
• W3209289701 cites W3031606268 @default.
• W3209289701 cites W3033412368 @default.
• W3209289701 doi "https://doi.org/10.1016/j.phymed.2021.153843" @default.
• W3209289701 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34785414" @default.
• W3209289701 hasPublicationYear "2022" @default.
• W3209289701 type Work @default.
• W3209289701 sameAs 3209289701 @default.
• W3209289701 citedByCount "5" @default.
• W3209289701 countsByYear W32092897012022 @default.
• W3209289701 countsByYear W32092897012023 @default.
• W3209289701 crossrefType "journal-article" @default.
• W3209289701 hasAuthorship W3209289701A5000776473 @default.
• W3209289701 hasAuthorship W3209289701A5007506985 @default.
• W3209289701 hasAuthorship W3209289701A5009827155 @default.
• W3209289701 hasAuthorship W3209289701A5021604240 @default.
• W3209289701 hasAuthorship W3209289701A5026424113 @default.
• W3209289701 hasAuthorship W3209289701A5043614299 @default.
• W3209289701 hasAuthorship W3209289701A5048082989 @default.
• W3209289701 hasAuthorship W3209289701A5048301510 @default.
• W3209289701 hasAuthorship W3209289701A5048718447 @default.
• W3209289701 hasAuthorship W3209289701A5052212622 @default.
• W3209289701 hasAuthorship W3209289701A5068313104 @default.
• W3209289701 hasAuthorship W3209289701A5077541525 @default.
• W3209289701 hasAuthorship W3209289701A5080815038 @default.
• W3209289701 hasAuthorship W3209289701A5083114703 @default.
• W3209289701 hasAuthorship W3209289701A5085214820 @default.
• W3209289701 hasAuthorship W3209289701A5085368591 @default.
• W3209289701 hasAuthorship W3209289701A5090914980 @default.
• W3209289701 hasAuthorship W3209289701A5091138158 @default.
• W3209289701 hasConcept C11960822 @default.
• W3209289701 hasConcept C122927707 @default.
• W3209289701 hasConcept C126322002 @default.
• W3209289701 hasConcept C134018914 @default.
• W3209289701 hasConcept C141359234 @default.
• W3209289701 hasConcept C151955695 @default.
• W3209289701 hasConcept C171089720 @default.
• W3209289701 hasConcept C181199279 @default.
• W3209289701 hasConcept C185592680 @default.
• W3209289701 hasConcept C2779728014 @default.
• W3209289701 hasConcept C2780124434 @default.
• W3209289701 hasConcept C53007507 @default.
• W3209289701 hasConcept C55493867 @default.
• W3209289701 hasConcept C71924100 @default.
• W3209289701 hasConcept C97029542 @default.
• W3209289701 hasConcept C98274493 @default.
• W3209289701 hasConceptScore W3209289701C11960822 @default.
• W3209289701 hasConceptScore W3209289701C122927707 @default.
• W3209289701 hasConceptScore W3209289701C126322002 @default.
• W3209289701 hasConceptScore W3209289701C134018914 @default.
• W3209289701 hasConceptScore W3209289701C141359234 @default.
• W3209289701 hasConceptScore W3209289701C151955695 @default.
• W3209289701 hasConceptScore W3209289701C171089720 @default.
• W3209289701 hasConceptScore W3209289701C181199279 @default.
• W3209289701 hasConceptScore W3209289701C185592680 @default.
• W3209289701 hasConceptScore W3209289701C2779728014 @default.
• W3209289701 hasConceptScore W3209289701C2780124434 @default.

• next